DDI2 and cervical carcinoma: We confirm that FAM13A-AS1 upregulates DNA-damage inducible 1 homolog 2 (DDI2) expression through miRNA-205-3p to suppress cervical cancer progression, which implicates FAM13A-AS1 as a potential biomarker for cervical cancer treatments.